Bullish Case: NTES at $118.76 sits inside a mean-reverting regime with a $120 floor defended repeatedly. The Helium price-density has its largest mass at $110–$120 with a fat right shoulder toward $125–$130, and bullish risk runs 9% above bearish. Fresh catalysts support a drift higher: The Blood of Dawnwalker hitting 1M sales validates NetEase's studio-funding model, and Ananta's Jan 15, 2027 launch gives a dateable upside event. Contango term structure signals no near-term panic.

Bearish Case: NTES is down 22% year-over-year and the Helium AI forecast is -1.39% with a historically negative (-0.2) correlation to realized moves. Helium's density places peak probability at $110–$115, below spot, with a meaningful secondary lobe near $90 — a downside-shifted distribution versus the market's. Put volume exceeds calls by 18%, deep-OTM put vols (60–90 strikes, 40–80% IV) show durable crash-hedge demand, and option volume at the 0th percentile makes any flow signal fragile and exit liquidity poor.

Potential Outcomes:

1. 38% — Range $112–$124 through Dec 19 expiry; falsified by a close outside that band.
2. 27% — Slide to $105–$112 if $118 breaks on rising put skew; Helium density's $110 peak and $90 tail support this.
3. 20% — Rebound to $126–$132 on Ananta pre-launch hype or strong Q3 results; confirmed by call-heavy flow at 120–125 strikes.
4. 10% — Vol event (IV >45%, move >15%) from regulatory or game-delay news; watch Helium-vs-market IV gap widening.
5. 5% — Rally beyond $135 into January launch.

September 23, 2026